HIGHLIGHTS
- who: Fariborz Mansour-Ghanaei and collaborators from the Caspian Digestive Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran have published the research work: The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter p lori Eradication: A Randomized, Double-Blind Clinical Trial, in the Journal: Evidence-Based Complementary and Alternative Medicine of 28/Nov/2021
- what: Te BPAL-7 and BPAL-10 regimens were patientcompatible and well-tolerated.
SUMMARY
Helicobacter pylori (H. pylori) afects about 80% of the total population in developing countries and 20-50% in developed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.